Skip to content

Exact Sciences target upped to $45 by Cowen on Cologard survey

May 8, 2017

Cowen raised its price target on Exact Sciences (NASDAQ: EXAS) to $45.00 (from $40.00) while maintaining a Outperform rating after their Spring 2017 Cologuard Survey.

Doug Schenkel notes strong provider perception and projected uptake which boosts their confidence in the outlook for Cologuard demand over the next 3 years.

http://bit.ly/2pVvSdW

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: